🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Attentional disorders have been reported in neuropsychological studies eval...
Status
Terminated
Location
Hopital Roger Salengro, CHU Lille
Start Date
2022-04-26
Trial ID
NCT05530109
Treatments Being Tested
The main goal of this study is to quantitatively assess the sucking and fee...
Status
Terminated
Location
Boston Children's Hospital
Start Date
2017-03-29
Trial ID
NCT03246243
Treatments Being Tested
Investigation of (possible etiological) factors associated with PGAD sympto...
Status
Completed
Location
Hannover Medical School
Start Date
2020-06-01
Trial ID
NCT04566783
Multicenter prospective study comparing the diagnosis value of high-resolut...
Status
Completed
Location
University Hospital of Marseille
Start Date
2009-10
Trial ID
NCT01090934
Treatments Being Tested
This study will evaluate the decision-making ability and therapeutic effect...
Status
Not Yet Recruiting
Location
Shanghai Mental Health Center
Start Date
2025-08-11
Trial ID
NCT07115615
Treatments Being Tested
The goal of this research study is to learn how the brain areas that plan a...
Status
Recruiting
Location
University of Pittsburgh
Start Date
2025-05-27
Trial ID
NCT06458153
Treatments Being Tested
Opioid use disorder (OUD) remains a major public health problem particularl...
Status
Recruiting
Location
Yale Child Studies Center
Start Date
2023-01-01
Trial ID
NCT05495984
Treatments Being Tested
Recent data published by various laboratories as well as our preliminary da...
Status
Terminated
Location
CHU Amiens
Start Date
2012-05
Trial ID
NCT02799108
Epilepsy is frequently associated with cognitive and attentional disorders....
Status
Recruiting
Location
University Hospital,
Start Date
2024-03-04
Trial ID
NCT06466681
Treatments Being Tested
Parkinson's disease is the second most common neurodegenerative disease aft...
Status
Active Not Recruiting
Location
CHU de Rennes
Start Date
2023-05-03
Trial ID
NCT05808504
Treatments Being Tested